{"id":1267557,"title":"DSEN Abstract: Crizotinib and Incidence of Death: A Systematic Review and Network Meta-analysis of ALK Inhibitors for Non-small Cell Lung Cancer - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-26","captureTimestamp":"2026-03-26T22:07:29.170000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54496.html?wbdisable=true","snippet":"DSEN Abstract Crizotinib and Incidence of Death: A Systematic Review and Network Meta-analysis of ALK Inhibitors for Non-small Cell Lung Cancer Summary We observed that all ALK inhibitors improved progression-free survival relative to chemotherapy, and that alectinib and…","rawSnapshotUrl":"/api/snapshots/raw/1267557","browseUrl":"https://replay.healtharchive.ca/job-8/20260326220729/https://cihr-irsc.gc.ca/e/54496.html?wbdisable=true#ha_snapshot=1267557","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}